NYSE:NNVC

NanoViricides Stock Forecast, Price & News

$3.88

-0.02 (-0.51 %)

(As of 10/21/2020 12:00 AM ET)

Add

Compare

Today's Range

$3.80

Now: $3.88▼

$3.92

50-Day Range N/A

52-Week Range

$1.85

Now: $3.88▼

$19.20

Volume81,900 shs

Average Volume2.09 million shs

Market Capitalization$41.34 million

P/E RatioN/A

Dividend YieldN/A

Beta0.66

NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of all types of Dengue viruses; and HIVCide that is an escape-resistant anti-HIV nanoviricide. In addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for NanoViricides.

0.0 Community Rank

Outperform Votes
NanoViricides has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
NanoViricides has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about NanoViricides and other stocks. Vote “Outperform” if you believe NNVC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NNVC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
NanoViricides does not currently pay a dividend.
Dividend Growth
NanoViricides does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, NanoViricides insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 14.80% of the stock of NanoViricides is held by insiders.
Percentage Held by Institutions
Only 7.11% of the stock of NanoViricides is held by institutions.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of NanoViricides is -1.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of NanoViricides is -1.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
NanoViricides has a P/B Ratio of 1.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.00 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Commercial physical research

Sub-IndustryN/A

SectorMedical

Current SymbolNYSE:NNVC

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.nanoviricides.com

Phone203-937-6137

Employees17

Debt

Debt-to-Equity RatioN/A

Current Ratio2.91

Quick Ratio2.91

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book Value$2.76 per share

Price / Book1.41

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-8,420,000.00

Net MarginsN/A

Return on Equity-73.41%

Return on Assets-57.43%

Miscellaneous

Outstanding Shares10,654,000

Market Cap$41.34 million

Next Earnings DateN/A

OptionableOptionable

$3.88

-0.02 (-0.51 %)

(As of 10/21/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive NNVC News and Ratings via Email

Sign-up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.

NanoViricides (NYSE:NNVC) Frequently Asked Questions

Who are some of NanoViricides' key competitors?

Some companies that are related to NanoViricides include Auxly Cannabis Group (CBWTF), Pieris Pharmaceuticals (PIRS), Eloxx Pharmaceuticals (ELOX), Eloxx Pharmaceuticals (ELOX), Bioanalytical Systems (BASI), ProMIS Neurosciences (ARFXF), Cleveland BioLabs (CBLI), Inhibitor Therapeutics (INTI), HedgePath Pharmaceuticals (HPPI), AIkido Pharma (AIKI), Tenax Therapeutics (TENX), Vitality Biopharma (VBIO), US Stem Cell (USRM), Protalex (PRTX) and ALGAE TEC LTD/S (ALGXY).
View all competitors.

Who are NanoViricides' key executives?

NanoViricides' management team includes the following people:

Dr. Anil R. Diwan, Exec. Chairman, Pres, Acting CEO & Sec. (Age 61, Pay $400k)
Ms. Meeta R. Vyas B.S., M.B.A., SB, MBA, Chief Financial Officer (Age 61, Pay $154.09k)
Dr. Irach B. Taraporewala, Consultant (Age 64, Pay $419.48k)
Dr. Randall W. Barton Ph.D., Chief Scientific Officer & Chief Regulatory Officer (Age 73)

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE) under the ticker symbol "NNVC."

How do I buy shares of NanoViricides?

Shares of NNVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NanoViricides' stock price today?

One share of NNVC stock can currently be purchased for approximately $3.88.

How big of a company is NanoViricides?

NanoViricides has a market capitalization of $41.34 million. NanoViricides employs 17 workers across the globe.

What is NanoViricides' official website?

The official website for NanoViricides is www.nanoviricides.com.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Drive, Shelton CT, 06484. The company can be reached via phone at 203-937-6137 or via email at [email protected]

This page was last updated on 10/22/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings